DOCSLIB.ORG

2007 Annual Report Annual Institute Eye Lions Review Molecular

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2007 Annual Report Annual Institute Eye Lions Review Molecular Lions Eye Institute ABN 48 106 521 439 2 Verdun Street, Nedlands WA 6009 General Administration & Research Enquiries 9381 0777 Administration & Research Facsimile 9381 0700 07 International +61 8 9381 0777 Clinical Facilities Elsie Gadd Eye Clinic Appointments 9381 0888 Day Surgery Facility 9381 0880 Laser Vision Centre 9381 0758 Clinical Facilities Facsimile 9382 1171 Annual REPORT 20 WWW.LEI.ORG.AU RAZOREYE LEI5693 02/08 Lions Eye Institute 2007 Annual Report Annual Report 2007 Corporate Directory Mission Lions Eye Institute Prof. Ian Constable AO Assoc. Prof. Geoffrey Crawford Administration & Finance Our mission is to achieve excellence Managing Director Director of Surgical Services [email protected] [email protected] Chee-Peng Yao in scientific research and clinical practice 9381 0871 Chief Financial Officer Esther McCloskey [email protected] to prevent blindness. Executive Assistant to Prof. Constable Assoc. Prof. Graham Barrett 9381 0703 [email protected] [email protected] 9381 0882 9381 0872 David Eiszele Dr Jean-Louis deSousa Information Technology Chairman [email protected] & Communications 9381 0777 9381 0747 Yaasin Lutta Dr Adam Gajdatsy Head of Information Technology [email protected] & Communications Research 9381 0763 [email protected] 9381 0786 Prof. P. Elizabeth Rakoczy Dr Antonio Giubilato Director of Research; [email protected] Director, Molecular Ophthalmology 9381 0819 [email protected] Lions Eye Bank 9381 0726 Dr Tim Isaacs [email protected] Stephanie Durham Coordinator Assoc. Prof. Mariapia Degli-Esposti 9381 0862 Co-Director, Centre for Experimental [email protected] Immunology; Assoc. Prof. William Morgan 9381 0770 Director, Molecular Immunology & Virology Co-Director, McCusker Glaucoma Centre [email protected] [email protected] 9381 0808 9381 0873 Lions Optics Prof. Yogesan Kanagasingam Dr Mei-Ling Tay-Kearney Michelle Newton Director, Centre for e-Health [email protected] Manager [email protected] 9381 0875 [email protected] 9381 0817 Dr Steven Wiffen 9381 3860 Dr Anthony Scalzo Director, Lions Eye Bank Co-Director, Centre for Experimental [email protected] Immunology; 9381 0874 Lions Save-Sight Foundation Director, Viral Immunogenetics Elizabeth Zambotti Lorraine Strickland [email protected] Director of Nursing Chair of Board 9381 0754 [email protected] Gail Mason 9381 0813 Prof. Dao-Yi Yu Office Manager Director, Physiology & Pharmacology; [email protected] Co-Director, McCusker Glaucoma Centre 9381 0767 [email protected] Development 9381 0716 Helen Rowe Director of Development Australian Foundation [email protected] for the Prevention of Blindness Clinicians 9381 0823 Chee-Peng Yao Assoc. Prof. Ian McAllister Development & Media Group [email protected] Director of Clinical Services 9381 0708 9381 0703 [email protected] 9381 0870 Bequest & Donation Enquiries 9381 0708 2007 Annual Report Lions Eye Institute CChairman’son Report tents2 Managing Director’s Report 4 Our Board 6 Corporate Governance Statement 8 Review - Centre for e-Health 9 Review - Clinical Research 10 Review - Physiology & Pharmacology Group 11 Review - Molecular Ophthalmology Group 12 Review - Molecular Immunology & Virology Group 14 Review - Viral Immunogenetics Group 16 Our Clinical Services 18 Our Clinicians 22 Our Shared Vision 24 A Lasting Legacy 28 Appointments, Awards & Honours 30 Collaborators & Visitors 34 Conferences & Invited Lectures 36 Publications 40 Grants 43 Financial Statements - Lions Eye Institute Limited 46 Financial Statements - Australian Foundation for the Prevention of Blindness Trust 48 Corporate Directory 49 “Every five seconds one person in our world goes blind. Every minute a child goes blind. The implications of visual disability are enormous. The public imperative of blindness cannot be ignored.” Prof. Ian Constable AO Lions Eye Institute Annual Report 2007 Chairman’s 2 Report The LEI Board and its management are pleased with the progress of the many programs contained within the Institute’s three year strategic plan. Following a highly successful Board and management workshop held in June it was agreed that the rapid growth expected at LEI in the near future necessitated a change in focus. I am therefore pleased to advise that LEI’s newly defined principal objective is, “To achieve excellence in scientific research and clinical practice to prevent blindness.” LEI will focus on introducing new initiatives in science and clinical ophthalmology and securing the vigorous leadership to make these initiatives happen. Such initiatives will require a re-evaluation of our revenue raising programs and a continuation of sound financial management. In 2007 LEI achieved a net surplus in General Member funds of $0.9m. This surplus was achieved from revenue of $8.7m comprised of $8.2m from clinical services and $0.5m from bequests and donations. LEI holds net assets of $17.4m of which $7.1m is in property, plant and equipment. In my last report I welcomed commitments from the Western Australian Government and The 2007 University of Western Australia (UWA) towards and development of telescopes over the past 400 co-funding the establishment of two new medical years has allowed humankind to step outside its own research facilities at the QEII Medical Centre and the solar system and begin a voyage of discovery back to Fiona Stanley Campus. the birth of the cosmos. Annual Report During the year the Membership of LEI’s Board remained unchanged during the year and it focussed heavily on the new Federal Government announced strategic direction and executive succession planning. I thank the Directors for their contribution, support substantial financial support Lions Eye Institute and guidance in the team effort required to achieve for the project and the Western LEI’s principal objective. 3 Australian Institutes of Health, In 2008 LEI will celebrate its 25th anniversary. Brian of which LEI is a member, King was the Institute’s inaugural Chairman and Prof. Ian Constable its Founding Director. LEI is indeed is now managing this significant fortunate that these two key people responsible for its investment in health and medical founding are still involved in its activities today. research infrastructure. In the past LEI has received outstanding support from the Lions Save-Sight Foundation (LSSF) and the Architects and building consultants have been Australian Foundation for the Prevention of Blindness appointed and LEI will take space in both the QEII and I look forward to their ongoing support of the and Fiona Stanley facilities for research purposes. challenging research initiatives planned for 2008. It The planning and design of the QEII medical research has been a pleasure working with Prof. Constable building will accelerate next year and it is hoped and the LEI staff over the past three years and I thank construction will be underway by late 2008. In them all on behalf of the Board for their collective preparation for the new research building, LEI’s effort for LEI. management will step up their efforts to recruit key scientists and researchers. David Eiszele Throughout the year our researchers and scientists attracted research funding of $2.9m. It is expected that new initiatives envisaged in the latest strategic plan will ensure future success for LEI by attracting additional research funding to meet our expansion plans. LEI remained a world leader in both research and clinical excellence in 2007. Our gene therapy project as a treatment for age related macular degeneration progressed towards the clinical trial stage while our glaucoma research in the USA also produced very encouraging results. On the clinical front, the Laser Vision Centre’s acquisition of the world’s most advanced LASIK vision correction technology, the 100% blade-free IntraLase Method, further enhanced the standard of care and treatment options available to our patients. Another highlight was the Ian Constable Lecture presented by Prof. Peter Quinn, Premier’s Fellow at the School of Physics at UWA. In excess of 550 people attended this free public lecture which acknowledges Prof. Constable’s achievements as the University’s founding Professor of Ophthalmology. Prof. Quinn’s lecture focussed on how the invention Prof. Peter Quinn, orator of the 2007 Ian Constable Lecture, with Prof. Ian Constable AO. Lions Eye Institute Annual Report 2007 Managing 4 Director’s Report Our Institute continues to fill a major role locally, nationally and in the region. We conduct medical scientific research of the highest international calibre and provide world’s best practice medical eye care to almost 50,000 patients each year. In 2007 the newly promoted Assoc. Prof. Bill Morgan implanted our first dissolving glaucoma tube in a patient suffering from glaucoma. Prof. Dao-Yi Yu and Assoc. Prof. Steven Cringle are the scientific team leaders on this project which is a world first and a product of a major National Health & Medical Research Council (NHMRC) Program Grant. During the year extensive additional preparatory work was carried out by Prof. Elizabeth Rakoczy and her team to gain national approval to carry out the world’s first clinical trial of secretion gene therapy for wet macular degeneration. We were delighted to welcome to the Institute Prof. Paul McMenamin, distinguished eye researcher, Associate Dean of Teaching and Learning at UWA’s Faculty of Medicine, Dentistry and Health Sciences, and senior member of the School of Anatomy and Human Biology. Prof. McMenamin and his team of postdoctoral, doctoral and honours students add greatly to the core scientific strength of the Institute and will collaborate with molecular immunology, virology and immunogenetics groups 2007 headed by Assoc. Prof. Mariapia Degli-Esposti and has proceeded to develop major new research Dr Tony Scalzo. facilities for Western Australia. Chairman David Eiszele and I sit on the overarching Implementation Our Telemedicine Group headed by Prof. Yogesan Committee and are pleased with the progress that Annual Report Kanagasingam signed a licensing agreement through has been achieved.
Load more

Recommended publications
  • Finding Cures for Cardiovascular Disease Through World-Class Medical Research 02 VICTOR CHANG CARDIAC RESEARCH INSTITUTE IMPACT REPORT 2019 03
    IMPACT REPORT 2019 Finding cures for cardiovascular disease through world-class medical research 02 VICTOR CHANG CARDIAC RESEARCH INSTITUTE IMPACT REPORT 2019 03 For years the Victor Chang Cardiac Research Institute has Contents been Australia’s home of heart research. Since , the Institute has made an unshakeable contribution to the fight against About Us 4 Heart Disease Statistics 6 cardiovascular disease, and that PATIENT STORY SCAD Survivor 8 makes us overwhelmingly proud. Chairman’s Report 10 Executive Director’s Report 14 In ­­ we farewell our PATIENT STORY Cardiac Arrest Survivor 16 Organisational Structure 17 pioneering Executive Director, Board of Directors 18 Professor Bob Graham. 25 years of discovery 20 PROFILE Professor Bob Graham 24 Nevertheless, we are confident PROFILE Professor Diane Fatkin 34 that in Professor Jason Kovacic PROFILE Professor Livia Hool 38 Research Divisions Overview 42 we have a champion who will not Victor Chang Cardiac Research Institute Innovation Centre 44 only continue this legacy but take Sohn Hearts & Minds the Institute to the next level, as Investment Leaders Conference 46 Heart Health Checks 48 the new leader of the organisation. Statement of Income and Expenditure 49 Achievements and Awards 50 Fundraising Events 52 Supporters and Acknowledgments 54 This special 25th Anniversary edition is dedicated Support Life-Saving Heart Research 57 to you, our loyal supporters. After a quarter of a century, thanks to you, we’re only just getting started. Here’s to another 25 illustrious years! 04 VICTOR CHANG CARDIAC RESEARCH INSTITUTE IMPACT REPORT 2019 05 About Us Our Mission Our Statistics Australia’s home The relief of pain and suffering and the promotion of wellbeing, of heart research through an understanding of the fundamental The Victor Chang Cardiac Research mechanisms of researchers and staff cardiovascular biology in Institute is dedicated to finding cures health and disease.
    [Show full text]
  • Today's Research Tomorrow's Cure
    2018 Heart Research Institute Annual Review Accelerating Research Tomorrow’s cure Tomorrow’s Today’s research Today’s 2018 Heart Research Institute Annual Review Hello Future Accelerating 2018 Heart Research Institute Annual Review Research ACCELERATING Discoveries into therapies Knowledge into prevention Breakthroughs into cures Students into leaders Collaborations into partnerships 4 2018 Heart Research Institute Annual Review Inspiring Leaders 2018 Heart Research Institute Annual Review CONTENTS 06 HRI in 2018 08 Chairman’s Report 2018 10 Director of Cardiovascular Research Report 12 2018 Research and Media Highlights 16 Applied Materials Group 18 Atherosclerosis and Vascular Remodelling Group 20 Cardiac Imaging Group 22 Cardiometabolic Disease Group 24 Cardiovascular Medical Devices Group 26 Cell Therapeutics Group 28 Clinical Research Group 30 Haematology Research Group 32 Heart Rhythm and Stroke Prevention Group 34 High Blood Pressure Group 36 Thrombosis Group 38 Vascular Complications Group 40 Vascular Immunology Group 42 Inflammation and Fibrosis Research 44 PhD Students 45 Select Prizes and Awards 46 Select Conferences and Presentations 50 Select Publications 56 Board of Governors 59 International Board of Governors 60 Members of the Institute 62 Fundraising Report 66 Operations Report 6 2018 Heart Research Institute Annual Review The mission of the Heart Research Institute (HRI) is to prevent death and suffering from cardiovascular disease through an understanding of the biological processes that cause atherosclerosis and thrombosis, the major underlying causes of most heart attacks and strokes. 20 18 SHORT TERM LONG TERM The major short-term focus of our research There are four long-term objectives is to understand the development and for our research: progression of atherothrombotic conditions • To investigate mechanisms in which the arteries are narrowed and contributing to the pathogenesis restricted due to a build-up of fatty of cardiovascular disease.
    [Show full text]
  • Annual Report 2005, Baker Heart Research Institute
    Baker Heart Research Institute | Annual Report 2005 Annual Report 2005 Contents 2 The Baker story 4 Organisational Structure 6 Director’s Report 8 President’s Report 9 A word from our patron 10 The Board 12 Baker History 14 Summary of Baker relationships 15 Research & Divisions 16 Baker Clinical 17 ABMU 18 Experimental Cardiology and Heart Failure 19 Wynn Department of Cardiology 20 Cellular Biochemistry 21 Experimental Cardiology 22 Cardiac Hypertrophy 23 Cardiac Surgery 24 Applied Cardiovascular Research 25 Molecular Endocrinology 26 Molecular Pharmacology 27 Atherothrombosis and Vascular 28 Thrombosis & Myocardial Infarction 29 Cell Biology 30 Clinical Physiology 31 Vascular Pharmacology 32 Cell Biology & Diabetes 33 Lipoproteins & Atherosclerosis 34 Human & Vascular Biology 35 JDRF Diabetes and Metabolism 36 Oxidative Stress 37 Human Epigenetics 38 Biochemistry of Diabetic Complications 39 Kidney Disease in Diabetic Complications 40 Advanced Glycation in Diabetic Complications 41 Genomics of Diabetic Complications 42 Proliferation & Fibrosis in Diabetic Complications 43 Atherosclerosis in Diabetic Complications 44 Cardiovascular Neuroscience 45 Neuropharmacology 46 Translational Proteomics Ramaciotti Centre 47 Human Neurotransmitters 48 Commercialisation 60 Core Facilities 62 Staff & Students 66 Monthly Baker Science Awards 68 Development 67 Donors 70 Financial Report 73 Publications 76 Location & Contact details now in its 80th year, the Baker A comprehensive research Heart Research Institute is program with a strategic focus: The Baker story… Australia’s most distinguished Research at the Baker is broadly cardiovascular research centre divided into four divisions: and one of the world’s leading Experimental Cardiology and Heart organisations investigating Failure; Atherothrombosis and the causes and complications, Vascular; Diabetes and Metabolism treatment and prevention of heart, and Cardiovascular Neuroscience.
    [Show full text]
  • Snow Fellowship 2021 Application Round - Eligible Host Organisations
    Snow Fellowship 2021 Application Round - Eligible Host Organisations Entity name Asbestos Diseases Research Institute Australian Catholic University Limited Australian Centre for Heart Health Australian Institute of Aboriginal and Torres Strait Islander Studies Australian National University Baker Heart and Diabetes Institute Bionics Institute Black Dog Institute Bond University Limited Brien Holden Vision Institute Burnet Institute Centenary Institute of Cancer Medicine and Cell Biology Central Australian Aboriginal Congress Aboriginal Corporation Central Queensland University Centre for Eye Research Australia Limited Charles Darwin University Charles Sturt University Children's Cancer Institute Children's Medical Research Institute Chris O'Brien Lighthouse Curtin University Deakin University Doherty Institute Ear Science Institute Australia Incorporated Edith Cowan University Federation University Australia Flinders University Florey Institute of Neuroscience and Mental Health Garvan Institute of Medical Research George Institute for Global Health Griffith University Hanson Institute Harry Perkins Institute of Medical Research Heart Research Institute Hudson Institute of Medical Research Hunter Medical Research Institute Ingham Institute Institute for Breathing and Sleep James Cook University Kolling Institute of Medical Research La Trobe University Lions Eye Institute Macquarie University Snow Fellowship 2021 Application Round - Eligible Host Organisations Mater Research Limited Melanoma Institute Australia Menzies School of Health
    [Show full text]
  • Snow Fellowships 2020 Application Round - Eligible Host Organisations
    Snow Fellowships 2020 Application Round - Eligible Host Organisations Entity name Asbestos Diseases Research Institute Australian Catholic University Limited Australian Centre for Heart Health Australian Institute of Aboriginal and Torres Strait Islander Studies Australian National University Baker Heart and Diabetes Institute Bionics Institute Black Dog Institute Bond University Limited Brien Holden Vision Institute Burnet Institute Centenary Institute of Cancer Medicine and Cell Biology Central Australian Aboriginal Congress Aboriginal Corporation Central Queensland University Centre for Eye Research Australia Limited Charles Darwin University Charles Sturt University Children's Cancer Institute Children's Medical Research Institute Chris O'Brien Lighthouse Curtin University Deakin University Doherty Institute Ear Science Institute Australia Incorporated Edith Cowan University Federation University Australia Flinders University Florey Institute of Neuroscience and Mental Health Garvan Institute of Medical Research George Institute for Global Health Griffith University Hanson Institute Harry Perkins Institute of Medical Research Heart Research Institute Hudson Institute of Medical Research Hunter Medical Research Institute Ingham Institute Institute for Breathing and Sleep James Cook University Kolling Institute of Medical Research La Trobe University Lions Eye Institute Macquarie University Mater Research Limited Melanoma Institute Australia Menzies School of Health Research Monash University Murdoch Children’s Research Institute Murdoch
    [Show full text]
  • Annual Scientific Meeting of the Australian Atherosclerosis Society October 21 – 23, 2015, Fremantle, Western Australia Faculty Member Biographies
    Annual Scientific Meeting of the Australian Atherosclerosis Society October 21 – 23, 2015, Fremantle, Western Australia Faculty Member Biographies International Guest Speakers: Prof. Bart Staels, Pasteur Institute, Lille, France Prof. Bart Staels’ research focuses on molecular pharmacology of cardiovascular and metabolic diseases, including dyslipidemia and type 2 diabetes. He particularly studies the role of nuclear receptors (such as the PPARs, FXR, Rev-erba and RORa) in the control of inflammation and lipid and glucose homeostasis as well as the transcriptional mechanisms involved. Pr. Staels was among the first to identify a crucial role for the nuclear receptor PPARa in the control of lipid and glucose metabolism as well as cardiovascular function in humans. Dr Jean-Sébastien Silvestre From 1999 to 2007, he has been assistant professor at Paris-Diderot University and an honorary member of Institute Universitaire de France. Since 2008, he is research director at Institute Nationale de la Santé et de la Recherche Médicale (Inserm) and head of team 6 ‘regenerative therapies for cardiac and vascular diseases’ at the Paris Cardiovascular Research Center-Inserm UMRS 970 (Paris, France). His central interest lies in cardiovascular physiology and the role of vascular growth and remodelling in ischemic diseases. He has co-authored more than 100 published articles deciphering the molecular and cellular mechanisms involved in post-ischemic revascularization and tissue regeneration. Dr Bhama Ramkhelawon New York University Langone Medical Center Postdoctoral Fellow Bhama’s continuous eagerness to learn biological sciences brought her from Mauritius to France, where she obtained her PhD in cardiovascular diseases. She then moved to New York to gain expertise in the field of cardio-metabolic pathologies.
    [Show full text]
  • Menzies Research Institute Annual Report 2007 About Us
    Menzies Research Institute Annual Report 2007 About us At the Menzies Research Institute In 2000, the Tasmanian Government Our Research our aspiration is to contribute named Menzies a “Tasmanian Menzies’ researchers are currently significantly to improving human Icon” in recognition of our scientific working on over 100 projects that health and wellbeing. achievements, status and place in focus on preventing or curing a range the Tasmanian community. Menzies is renowned locally, nationally of diseases, including heart disease, and internationally for its research We underwent significant governance cancer, dementia, multiple sclerosis, excellence that utilises the competitive and structural changes in 2004, diabetes, cystic fibrosis, arthritis, advantages Tasmania has to offer. including a name change to the osteoporosis and mental health. Menzies Research Institute and the We are finding answers to local The research program at Menzies appointment of an independent Board. health problems that have global is organised around themes of significance. A significant ongoing growth research excellence: strategy was implemented in • Biostatistics; Tasmania is an ideal environment 2006 which saw Menzies undergo with many competitive advantages • Cancer; a dynamic transformation. We for medical research to thrive, • Cardiovascular Disease; became Tasmania’s premier medical including our small island research facility. Menzies’ research • Diabetes and Metabolism; geography, stable population, programs were expanded to focus • Genetics; extensive
    [Show full text]
  • NHMRC Administering Institutions List
    NHMRC Approved Administering Institutions This list is current as at 05 August 2020 and will be amended as required. The institutions listed below have been approved as Administering Institutions (https://nhmrc.gov.au/funding/manage-your-funding/nhmrcs-administering-institutions). Names appear as listed in NHMRC’s Research Grant Management System (RGMS). Administering Institutions are required to sign an NHMRC Funding Agreement prior to receiving any funds (https://nhmrc.gov.au/funding/manage-your-funding/funding-agreement-and-deeds-agreement) For any queries relating to approved Administering Institutions, please email [email protected]. # Entity name Australian Business Number (ABN) 1 Aboriginal Health and Medical Research Council of NSW 66085654397 2 ANZAC Research Institute 48066780055 3 Australia New Zealand Gynaecological Oncology Group 69138649028 4 Australian Catholic University Limited 15050192660 5 Australian Centre for Heart Health 87267901425 6 Australian Institute of Aboriginal and Torres Strait Islander Studies 62020533641 7 Australian National University 52234063906 8 Baker Heart and Diabetes Institute 98131762948 9 Bond University Limited 88010694121 10 Burnet Institute 49007349984 11 Cancer Council NSW 51116463846 12 Cancer Council Queensland 48321126727 13 Cancer Council Victoria 61426486715 14 Centenary Institute of Cancer Medicine and Cell Biology 22654201090 15 Central Adelaide Local Health Network Incorporated 96269526412 16 Central Australian Aboriginal Congress Aboriginal Corporation 76210591710
    [Show full text]
  • Enhancing the Commercialisation Outcomes of Health & Medical
    a Enhancing the commercialisation outcomes of health & medical research Supplementary submission to the Strategic Review of Health & Medical Research by the Association of Australian Medical Research Institutes (AAMRI) JULY / 2012 AAMRI / Supplementary submission to the McKeon Review COVER IMAGE: ©iStockphoto.com/askinkamberoglu AAMRI / Supplementary submission to the McKeon Review i Foreword The following submission is in response to a request from the McKeon Review Panel for ideas on how to increase the levels of commercially sponsored translation of Australian health and medical research. Partnership of researchers with commercial interests, including investors, venture capitalists and fund managers, as well as drug and device developers, is essential if patients are to benefit from the outcomes of health and medical research. In constructing this submission, AAMRI has therefore sought input from across the entire commercialisation ‘pipeline’. A round table discussion was held at the Baker IDI Heart and Diabetes Institute on Thursday 14 June 2012 to explore these issues. While this submission represents AAMRI’s interpretation of those discussions, all efforts have been made to represent and integrate the ideas and views of meeting participants. Round table participants > Anna-Maria Arabia, CEO, Science & Technology Australia > Dr Julian Clark, Head, Business Development, Walter & Eliza Hall Institute of Medical Research > Dr Nicole den Elzen, Executive Officer, Association of Australian Medical Research Institutes > Dr Leigh Farrell,
    [Show full text]
  • Annual Report | 2014
    Community A society that is well informed and values the benefits of health and medical research Investment Greater investment in health and medical research from all sources Prosperity Ensure Australia captures the benefits of health and medical research Position Promote Australia’s global position in health and medical research Mission To make health and medical research a higher priority for the nation Published November 2014 2 Board of Directors Research Australia’s Board reflects a balanced and effective governance structure. The membership contains technical expertise drawn from medical industry associations, medical research institutes, universities and philanthropic foundations, and companies. This technical expertise is complemented by members who bring professional expertise from business, finance, law, consumer advocacy, public policy and philanthropy. Chair Professor Janet Hiller Dean, School of Health Sciences, Professor Christine Bennett AO Swinburne University of Technology Dean of the School of Medicine, Sydney, Notre Dame University Mr Geoff Joyce Executive Director, Macquarie Capital Deputy Chair Mr Peter Wills AC Dr Anna Lavelle Respected research advocate CEO, AusBiotech Professor John McGrath Queensland Centre for Mental Health Ms Elizabeth Foley Research & Professor, Queensland Brain Managing Director, Institute, University of Queensland Research Australia Ltd Professor Alexandra McManus Dr Alison Butt Director, Centre of Excellence for Science Director, Research Investment, National Seafood & Health, Curtin University
    [Show full text]
  • Download a Pdf Version of the 2017 Convention Program
    2017 ANNUAL CONVENTION 6&7 December Hotel Realm 18 National Circuit, Barton, ACT AAMRI MEMBERS EVENT CONTACTS Peter Thomas, 0411 600 992, [email protected] Kathryn Naumenko, 0402 117 529, [email protected] Cath Latham, 0413 865 459, [email protected] 2 CONVENTION PROGRAM WED 6 DEC 9.00am REGISTRATION OPENS 9.30am-12.30pm MRI BUSINESS MANAGERS’ MEETING Pages 7-14 National Ballroom 2, Hotel Realm Canberra 12.30pm-1.30pm LUNCH National Ballroom 1, Hotel Realm Canberra 1.30pm-5.00pm AAMRI STRATEGY MEETING Pages 15-22 National Ballroom 2, Hotel Realm Canberra 5.30pm-6.30pm MRI BOARD MEMBER PRE-DINNER DRINKS High Courtyard South, Hotel Realm Canberra 6.30pm COURTESY BUSES FROM HOTEL REALM TO PARLIAMENT HOUSE Depart from the rear of Hotel Realm, in Burbury Close 7.00pm 2017 AAMRI ANNUAL DINNER Great Hall, Parliament House Guest speaker: The Hon Greg Hunt MP, Minister for Health, Minister for Sport 10.15PM Courtesy bus from Parliament House to Hotel Realm Canberra THURS 7 DEC 7.30am-8.30am AAMRI PRESIDENT’S BREAKFAST National Ballroom 2, Hotel Realm Canberra Guest speaker: The Hon Bill Shorten MP, Leader of the Opposition 8.45am-11.00am AAMRI AGM (REGISTRATION FROM 8.30AM) Pages 23-27 National Ballroom 2, Hotel Realm Canberra 3 PARTICIPANTS Mr Peter Allen Board Chair Wesley Medical Research Ms Gina Anderson Board Member The George Institute for Global Health Mr Richard Balderstone Board Olivia Newton-John Cancer Research Institute Dr Johanna Barclay Research Development Manager Mater Medical Research Institute Mr
    [Show full text]
  • Victor Chang Cardiac Research Institute | Impact Report 2018
    IMPAC T REPORT 2018 Finding cures for cardiovascular disease through medical research Heart attacks + stroke Stem cells Pregnancy + birth defects Life-saving Inherited heart disease research Heart transplants Genetic analysis Cardiac arrests ANNUAL REVIEW 2018 01 No.1 Cardiovascular disease is the number one cause of death globally Contents SUBJECT PAGE NO. About Us 02 The Problem 03 PREVENTING HEARTBREAK William’s Story 04 Chairman’s Report 06 42/wk 42 babies are born Executive Director’s Report 10 with a heart defect PREVENTING HEARTBREAK Liza’s Story 12 every week Organisational Structure 13 Board of Directors 14 The Power of Discovery 16 THE SOLUTION Seeing really is believing 18 THE SOLUTION Our ace of hearts 22 THE SOLUTION Sequence of success 26 Research Divisions 30 Victor Chang Cardiac Research Institute Innovation Centre 32 PREVENTING HEARTBREAK Fred’s Story 34 Statement of Income and Expenditure 35 Health Check Booth 36 Cover image. In a recent paper published in the Sohn Hearts & Minds prestigious journal Nature, Dr Gonzalo Del Monte Nieto, Investment Leaders Conference 38 Professor Richard Harvey and their colleagues put forward a new model for how the pumping chambers of the heart Achievements and Awards 40 form in the developing embryo. Central to this model is how fibrous extracellular material, called extracellular matrix, 42 Fundraising Events organises the growth of cardiac muscle cells, necessary for Supporters and Acknowledgments 44 proper heart function. This image is a view from inside the ventricles of the main pumping chamber of a developing Support Life-Saving Heart Research 49 heart, with cardiac muscle shown in red, and the extracellular matrix shown in blue.
    [Show full text]